Jessica's Universe
Compare yourself 4 years ago to yourself now.
Home
VAERS data analysis
VAERS in Substack
Good Morning CHD with Jessica Rose
Interviews
Presentations
CV/Publications
VAERS Publications
Resources
Blog
Better Way Conference: Dr. Jessica Rose
More
Dr Jessica Rose and Anna Blakney on The Middle Way Podcast 2021
Dr Jessica Rose 2023
Dr Jessica Rose 2022
NVICP Wk 8 - Dr Jessica Rose 2023
Testimony provided by Jessica Rose on day one of the National Citizens Inquiry hearing in Winnipeg, Manitoba.
Some presentations I have given to various organizations worldwide.
Original post on September 17, 2022
Dr. Jessica Rose presents data relating to fertility adverse events in the context of COVID-19 injections
February 5, 2022
This is probably the most important presentation anyone will see and certainly the most important one I have given.
August 24, 2022
This presentation is entitled: "What are the studies and data showing?: A focus on fertility"
November, 2021
I present data, evidence and ideas to Rabbinical Court Members to solve the COVID-19 crisis.
December, 2021
This is a presentation that I produced for the Israeli Knesset. I am still waiting for that meeting to happen.
January, 2022
This is a presentation I have at a very important symposium.
October 26, 2021
I presented VAERS data to the FDA as part of the 170th VRBPAC meeting to try to convince them not to put the shots into 5-11 years olds.
This is a slide deck I prepared for a court case in Australia.
This is a large slide deck of good material.
May 17, 2022
This is a clip of me talking at the event. My cat makes has a montage.
Original post on Sep 6, 2021
This is a valuable and relevant presentation that has been re-uploaded to Rumble.
December 22, 2021
Comparing analyses Rose and Su in the context of VAERS reports on myocarditis.
Original post on April 9, 2021
Jason Weeks speaks to Dr. Jessica Rose and Ilana Rachel Daniel as they go point-by-point through the Nuremberg Code.
Original post on January 24, 2023
Dr. Jessica Rose presents a detailed analysis of the problems associated with modified mRNA technology